Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/217719
Caspase-4 has potential utility as a colorectal tissue biomarker for dysplasia and early-stage cancer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background and Aims: Colorectal cancer (CRC) is the second most deadly cancer globally. The rapidly rising incidence rate of CRC, coupled with increased diagnoses in individuals <50 years, indicates that early detection of CRC, and those at an increased risk of CRC development, is paramount to improve the survival rates of these patients. Here, we profile caspase-4 expression across two distinct CRC development pathways, sporadic CRC (sCRC) and inflammatory bowel disease-associated CRC (IBD-CRC), to examine its utility as a novel biomarker for CRC risk and diagnosis. Methods: Tissue samples from patients with CRC, colonic polyps, IBD-associated CRC, and sporadic CRC were assessed by Immunohistochemistry (IHC) for caspase-4 expression in epithelial and stromal compartments. RNAseq expression data for caspase-4 in CRC and normal tissue samples were mined from online databases. Results: Epithelial caspase-4 expression is selectively elevated in CRC tumour tissue compared to adjacent-normal tissue, where it is not expressed. In the sCRC pathway, caspase-4 is expressed in the epithelial and stromal tissue of all histological subtypes of colonic polyps, with a significant increase in epithelial expression from LGD to HGD progression. For the IBDCRC pathway, caspase-4 epithelial expression was specifically upregulated in dysplastic and neoplastic tissue of IBD-CRC but was not expressed in normal or inflamed tissue. Conclusions: This study demonstrates that epithelial caspase-4 is selectively expressed in colon tissue during the development of dysplasia. As such, epithelial caspase-4 represents a promising novel tissue biomarker for CRC risk and diagnosis.
Matèries (anglès)
Citació
Citació
KANE, Laura e., FLOOD, Brian, MANILS PACHECO, Joan, MCSKEANE, Donna e., SMITH, Aoife p., TOSETTO, Miriam, ALALAWI, Fatema, FAY, Joanna, KAY, Elaine w., DUNNE, Cara, MCQUAID, Stephen, LOUGHREY, Maurice b., O’SULLIVAN, Jacintha, RYAN, Elizabeth j., SHEAHAN, Kieran, DOHERTY, Glen a., CREAGH, Emma m.. Caspase-4 has potential utility as a colorectal tissue biomarker for dysplasia and early-stage cancer. _Gastro Hep Advances_. 2024. Vol. 4, núm. 2. [consulta: 23 de gener de 2026]. ISSN: 2772-5723. [Disponible a: https://hdl.handle.net/2445/217719]